NOV 08, 2017 05:00 PM PST

Gibco™ Sera - Driving quality and innovation in a dynamic market

Speakers
  • Senior R&D Manager, Cell Biology, Thermo Fisher Scientific
    Biography
      Matt is currently a Senior Manager in Cell Biology Research and Development at Thermo Fisher Scientific. He obtained his Ph.D. in Chemical and Biomolecular Engineering from the Whiting School of Engineering at Johns Hopkins University, training that included a fellowship within the Johns Hopkins Institute for NanoBioTechnology, a multi-disciplinary institution with efforts spanning basic biological science, clinical science, and public health. Matt joined the Gibco R&D team in 2012 and has led development programs spanning oncology, primary human tissue culture, and stem cell biology. His current team is responsible for new product and process development in basal cell culture media, fetal bovine and other animal sera, and recombinant proteins.
    • Global Marketing Development Manager, Cell Biology, Thermo Fisher Scientific
      Biography
        Chris is a Global Marketing Development Manager in Cell Biology Research Sera at Thermo Fisher Scientific. He obtained his Bachelor of Science Business Administration majoring in Marketing from West Virginia University. Also, in 2013 he received an Associate of Applied Science in Nursing from Trocaire College. Chris joined the company back in 2006 as a Senior Marketing Program Manager and is currently based at the Grand Island, NY location which is home to the Gibco manufacturing site. He is responsible for all Gibco Sera marketing and programs that communicate the benefits of our Gibco cell culture products to researchers around the world.

      Abstract:

      In today’s volatile Fetal Bovine Sera market, it is critical for researchers to understand the complex nature of the market especially with demand escalating every year.  The demand for sera products has no direct impact on the supply of upstream raw materials, but it does influence cost.  Supply is finite because FBS is a byproduct of harvesting cattle for the meatpacking industry.  Over the last few years, the costs of raw materials needed to produce FBS have increased significantly due to limited supply in most geographical regions.  As a result, FBS suppliers were forced to increase pricing.  The FBS market is very dynamic, and changes can happen quickly.  Learn how Thermo Fisher Scientific the leading globe supplier of FBS is committed to investing in this the Sera business to ensure we can continue to provide the high quality and innovative products, with  the service that our customers have come to expect. 


      Show Resources
      You May Also Like
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      APR 27, 2018 10:00 AM PDT
      C.E. CREDITS
      APR 27, 2018 10:00 AM PDT
      DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
      AUG 15, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 15, 2018 08:00 AM PDT
      DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
      JUN 29, 2018 09:00 AM PDT
      C.E. CREDITS
      JUN 29, 2018 09:00 AM PDT
      DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
      MAY 29, 2018 09:00 AM PDT
      C.E. CREDITS
      MAY 29, 2018 09:00 AM PDT
      Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
      Loading Comments...